Women's health innovation, Gabon
Gabon
Gabon is a small, oil-dependent Central African economy with relatively high per-capita income but weak health outcomes for women. There is effectively no femtech startup sector, so this report centers on women's public health: maternal mortality remains around 227 per 100,000 live births, modern contraceptive use has fallen rather than risen, cervical cancer stays largely unaddressed because HPV vaccine is not in the national schedule, and HIV prevalence is comparatively high for the region. Recent movement is driven mostly by UNFPA, the World Bank-funded e-Gabon health information system, and academic screening research, not by private innovation.
Maternal deaths per 100,000 live births (2020, modeled estimate) data.worldbank.org
Modern contraceptive prevalence, down from 24% in 2012 (EDSG 2019-2021) gabon.unfpa.org
HPV prevalence among 1,524 women screened in Libreville Octobre Rose campaigns 2022-2024 nature.com
New cervical cancer cases and deaths in Gabon in 2023 nature.com
Recent developments
The most concrete recent activity sits in cervical cancer screening research, maternal care protocols, and the launch of a national digital health information system. Coverage is honest about gaps: HPV vaccine is still absent from routine immunization, and gender-based violence remains widely reported despite a 2021 law.
Policy and public health context
Women's health policy is shaped by UNFPA's 8th Country Programme, a 2021 law on violence against women, and the 2024-2028 national health development plan. The recurring theme is a gap between framework and delivery: strong stated goals, thin implementation and under-resourced services.
Ecosystem and organizations
There is no dedicated femtech industry in Gabon. The active players are UN agencies, government programs, academic research groups running cervical screening, and a small digital-entrepreneurship scene where women's initiatives appear mainly through the Ogooue Labs incubator rather than health-specific ventures.
Research and evidence
The strongest recent evidence base is academic: HPV burden studies from Libreville quantify cervical cancer risk and make the case for vaccination, especially among HIV-positive women. National survey and modeled estimates anchor the maternal and reproductive picture.
Recent developments
Policy and public health context
Ecosystem and organizations
Ecosystem by organisation type
Lead UN agency on reproductive health and family planning; supplies contraceptives, supports obstetric protocols and gender programs. gabon.unfpa.org
Annual campaign running since 2013 offering HPV testing and VIA/VILI cervical screening; source of recent national HPV epidemiology. nature.com
World Bank-funded national health information system deploying electronic records and telemedicine across facilities. gabonmediatime.com
Libreville incubator/school (founded 2013) supporting the digital economy; host to the Digi Women initiative promoting women in tech. ogoouelabs.com
Initiative running workshops and awards to bring more women into digital and AI-related careers in Gabon. gabonactu.com
Research and evidence
Sources and references
Every figure and claim above links back to a public source. 17 references, updated 2026-08.